2012
DOI: 10.1039/c2dt31360j
|View full text |Cite
|
Sign up to set email alerts
|

Remarkable in vitro bactericidal activity of bismuth(iii) sulfonates against Helicobacter pylori

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
42
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
2

Relationship

5
3

Authors

Journals

citations
Cited by 39 publications
(44 citation statements)
references
References 54 publications
2
42
0
Order By: Relevance
“…These activity results are comparable with the bismuth(III) sulfonate 70 and amino arenesulfonate 35 complexes. The inclusion of the nitrogen atom in the heterocycle showed no effects, as the tris-substituted bismuth(III) derived from L-proline, 2, displayed results that were comparable with exocyclic bismuth(III) compounds.…”
Section: General Observationssupporting
confidence: 64%
“…These activity results are comparable with the bismuth(III) sulfonate 70 and amino arenesulfonate 35 complexes. The inclusion of the nitrogen atom in the heterocycle showed no effects, as the tris-substituted bismuth(III) derived from L-proline, 2, displayed results that were comparable with exocyclic bismuth(III) compounds.…”
Section: General Observationssupporting
confidence: 64%
“…Our initial approach was to attempt to replicate our previous successful synthesis of hetero‐10 and homoleptic3 bismuth(III) sulfonates using [Bi(Ph) 3 ] through both solvent‐free (SF) and solvent‐mediated (SM) methods. An important driving force in both approaches is the elimination of benzene, with the ease of this protolysis reaction correlating loosely to the p K a value of the acid 11.…”
Section: Resultsmentioning
confidence: 99%
“…In particular, they form part of triple or quadruple therapies in the treatment and eradication of Helicobacter pylori, the bacterium responsible for gastritis, peptic‐ulcer disease and gastric cancer 2. We demonstrated recently that bismuth arenesulfonates show in vitro activity against H. pylori orders of magnitude greater than that observed for carboxylates, and thus had the potential to offer greater efficacy in significantly lower concentrations 3. Importantly, sulfonic acids are considered relatively benign, showing little or no mutagenic or carcinogenic activity towards mammalian cells 4.…”
Section: Introductionmentioning
confidence: 99%
“…pylori relative to BiPh 3 and the essentially ineffective sulfonic acids . The same or higher bactericidal activities have been determined for heteroleptic 5‐sulfosalicylates, homoleptic arenesulfonates, and aminoarenesulfonates . These bismuth sulfonates are more effective against H .…”
Section: Introductionmentioning
confidence: 62%